Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.520
+0.100 (2.92%)
May 21, 2026, 12:56 PM CET

Sprint Bioscience AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
108.33126.725.0649.9329.4970.64
Cash & Short-Term Investments
108.33126.725.0649.9329.4970.64
Cash Growth
476.68%405.68%-49.82%69.31%-58.25%160.92%
Accounts Receivable
-00.240.80.010.02
Other Receivables
7.126.1611.957.145.385.28
Receivables
7.126.1712.197.945.395.29
Total Current Assets
115.45132.8737.2457.8734.8875.94
Property, Plant & Equipment
3.473.744.724.382.372.99
Long-Term Investments
0.050.050.050.050.050.05
Other Long-Term Assets
0.010.010.050.080.120.16
Total Assets
118.97136.6642.0662.3837.4279.14
Accounts Payable
2.44.45.445.713.732.92
Accrued Expenses
-4.844.73.374.434.54
Current Unearned Revenue
--11.2312.32--
Other Current Liabilities
10.288.2411.4213.211.071.22
Total Current Liabilities
12.6917.4832.7834.69.238.68
Total Liabilities
12.6917.4832.7834.69.238.68
Common Stock
7.077.076.986.986.983.98
Additional Paid-In Capital
291.75291.75273.67273.9273.87258.97
Retained Earnings
-192.54-179.65-271.38-253.1-252.67-192.5
Shareholders' Equity
106.29119.189.2727.7728.1970.45
Total Liabilities & Equity
118.97136.6642.0662.3837.4279.14
Net Cash (Debt)
108.33126.725.0649.9329.4970.64
Net Cash Growth
476.68%405.68%-49.82%69.31%-58.25%313.73%
Net Cash Per Share
1.071.370.360.720.702.45
Filing Date Shares Outstanding
105.52105.5269.8269.8269.839.84
Total Common Shares Outstanding
105.52105.5269.8269.8269.839.84
Working Capital
102.76115.394.4623.2725.6567.25
Book Value Per Share
1.011.130.130.400.401.77
Tangible Book Value
106.29119.189.2727.7728.1970.45
Tangible Book Value Per Share
1.011.130.130.400.401.77
Machinery
-11.0510.969.667.217.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.